🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⁶⁸Ga-FAPI-04 PET/CT may be a more accurate PET tracer for diagnosing and staging solitary fibrous tumors than ¹⁸F-FDG, with a higher detection rate and tumor uptake in most organs involved. ow.ly/guGl50VjuKG #NuclearMedicine #PETscan #RPTherapy #Sarcoma

Fludeoxyglucose-18-PET response-guided salvage in relapsed classic Hodgkin lymphoma may identify patients in whom transplant-free salvage achieves excellent outcomes. ja.ma/4j5xfhV

Now out NatureRevClinOncol

Today NEJM Challenging dogma for routine surveillance imaging after cancer treatment The results of 12 randomized trials show no survival benefit, despite scans leading to more chemotherapy, surgery and radiation nejm.org/doi/full/10.10…

New #JITC article: Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study bit.ly/4dpztXb John Connolly

New AJR Accepted Manuscript: "Lung MRI: Indications, Capabilities, and Techniques—AJR Expert Panel Narrative Review" By Drs Azour, Ackman, & team ajronline.org/doi/10.2214/AJ…

Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 🔹️ICI for dMMR/MSI-H 🔹️Watch-and-wait approach 🔹️TNT/neoadj ChT 🔹️RT dose 🔹️Restaging timing 🔹️Local excision annalsofoncology.org/article/S0923-…

3/x PPV of prostate MRI varies widely by center pubs.rsna.org/doi/abs/10.114…

Pitfalls & pearls: experts on AI in radiology discuss best practices when evaluating algorithm bias Paul Yi St. Jude St. Jude Research Linda Moy Beepul Bharti Adway Kanhere @garin_SP Pranav Kulkarni Vishwa Parekh Samantha Santomartino Jeremias Sulam JHU Malone Center for Engineering in Healthcare Johns Hopkins BME bit.ly/45jxkdu

Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers NatureRevClinOncol doi.org/10.1038/s41571… 👏Excellent and very detailed summary on MSI-H/dMMR cancers ESMO - Eur. Oncology EASL Education ILCA

An exceptional new NEJM review on cancer of unknown origin nejm.org/doi/full/10.10…

Incorporating semiquantitative PET measures early after CAR T infusion imaging may help clinicians identify high-risk patients sooner. ow.ly/pb2a50VKLiu #NuclearMedicine #PETscan #Lymphoma Andrea Farolfi prof. Stefano Fanti Cristina Nanni

🔥 Hot off the press in European Radiology 🎯 New consensus recommendations from EORTC and ESGAR on imaging before and after locoregional treatments in patients with HCC 🔗link.springer.com/article/10.100…

Is long–axial-field-of-view PET/CT cost-effective? An international health–economic analysis. ow.ly/bYyT50VKLo9 #NuclearMedicine #PETscan #MedicalImaging BC Cancer UBC Radiology prof. Stefano Fanti Riccardo Mei

Phase 3 oncology RCTs often report positive results based on alternative end points, but actual improvements in overall survival or quality of life are rare, highlighting need to prioritize these outcomes in future research & regulatory processes. #ASCO25 ja.ma/3FCoVHI

Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4jyRiED

Metabolic tumor volume on ¹⁸F-FDG PET is a prognostic biomarker in patients with advanced gastroenteropancreatic neuroendocrine neoplasm. ow.ly/zz4K50W1Al8 #NuclearMedicine #PETscan #NeuroendocrineTumor

¹⁷⁷Lu-DOTATATE is cost-effective as a first-line treatment for patients with grade 2 or 3, well-differentiated, advanced gastroenteropancreatic #NeuroendocrineTumors. ow.ly/Zzw150W9YMP #NuclearMedicine Wolfgang Kunz Marcus Unterrainer MatthiasBrendel LenaUnterrainer

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4m3Eesv Alexander Sherry Bishal Gyawali, MD, PhD, FASCO Pavlos Msaouel Ethan Ludmir MD

🎯Increasing the CT attenuation threshold to 20 HU for lesions < 4 cm and eliminating washout CT for true adrenal incidentalomas, together with recommendations for endocrine assessment, will significantly decrease the over-investigation of overwhelmingly benign adrenal lesions.